Drugs in Context (Jun 2021)

Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

  • Sergey V Efimov,
  • Natallia V Matsiyeuskaya,
  • Olga V Boytsova,
  • Lyudmila Yu Akhieva,
  • Elena I Kvasova,
  • Francisco Harrison,
  • Yulia S Karpova,
  • Anton Tikhonov,
  • Nadezhda F Khomyakova,
  • Tim Hardman,
  • Jean-François Rossi

DOI
https://doi.org/10.7573/dic.2021-5-2
Journal volume & issue
Vol. 10
pp. 1 – 2

Abstract

Read online

The authors wish to make the following corrections to their article: Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study. Drugs in Context 2021; 10: 2021-11-1. DOI: 10.7573/dic.2020-11-1

Keywords